Glenmark Generics
May 16, 2012 at 12:24 | Source: Moneycontrol.com
May 09, 2012 at 12:08 | Source: Moneycontrol.com
May 09, 2012 at 11:42 | Source: CNBC-TV18
May 07, 2012 at 14:27 | Source: Moneycontrol.com
Apr 09, 2012 at 11:21 | Source: Moneycontrol.com
Apr 03, 2012 at 11:22 | Source: Moneycontrol.com
Videos »
Photos »
/ 
News across the web »
May 08, 2012 at 06:37 | Source: Business Standard
Apr 09, 2012 at 14:11 | Source: Business Today
Apr 09, 2012 at 14:00 | Source: NDTV Profit
Apr 09, 2012 at 11:07 | Source: India Infoline
Apr 03, 2012 at 11:02 | Source: India Infoline
Interact & exchange stock tips & market info »
Related News »
Glenmark Generics Inc. USA the United States subsidiary of Glenmark Generic Limited, announced today that the United States Food and Drug Administration (U.S. FDA) has granted tentative approval for zolmitriptan orally disintegrating tablets ...
May 16, 2012 at 07:17 | Source: equitybulls.com
464.03 crore for the corresponding previous quarter, registering growth of 28%. Glenmark, through its arm Glenmark Generics, launched 12 products in the US market in FY12, most of which were in the dermatology and oral contraceptive segments.
May 25, 2012 at 15:13 | Source: equitybulls.com
At a time when most Indian drug makers are launching generics to monetise patent expiries in the US, Glenmark has chosen to walk a road less travelled. The company has chosen a strategy to capture niche segments with limited competition, such as ...
May 20, 2012 at 19:01 | Source: Business Standard
(RTTNews) - Glenmark Pharmaceuticals Ltd. said its US subsidiary Glenmark Generics Inc. has obtained tentative approval from US FDA for Zolmitriptan orally disintegrating tablets, its generic version of AstraZeneca's Zomig-ZMT tablets. The tentative ...
May 16, 2012 at 06:56 | Source: RTT News
Glenmark Generics Inc, the US arm of Glenmark Generic has received tentative approval from United States Food and Drug Administration (USFDA) for zolmitriptan orally disintegrating tablets, Glenmark Pharmaceuticals said in a statement. The approval is for ...
May 16, 2012 at 12:32 | Source: MSN India
Glenmark Pharma 's US generics arm has received tentative approval from US Food and Drugs Administration (FDA) for Zolmitriptan orally disintegrating tablets, its copy of AstraZeneca's ZomigZMT tablets. The drug is used to treat acute migraine attacks.
May 16, 2012 at 06:42 | Source: MoneyControl.com
Glenmark's different route to US drug market 21-MAY-12 At a time when most Indian drug makers are launching generics to monetise patent expiries in the US, Glenmark has chosen to walk a road less travelled. The company has chosen a strategy to capture ...
May 24, 2012 at 19:32 | Source: Business Standard
The United States Food and Drug Administration (FDA) has granted tentative approval for Glenmark Generics Inc's (GGI), a US based subsidiary of Glenmark Pharmaceuticals Ltd, zolmitriptan orally disintegrating tablets, the generic version of AstraZeneca's ...
May 16, 2012 at 07:46 | Source: pharmabiz.com
Among key business segments, revenue from Glenmark's generics business rose 48% in the quarter, while speciality business saw 28% growth in Jan-March. It has allocated Rs 250 crore on capital expenditure this year and plans to spend 6-7% of ...
May 9, 2012 at 06:28 | Source: MoneyControl.com
Glenmark: It was the outperformer among peers in April with ... The CVS segment has witnessed strong traction, driven by branded generics. It has leadership in vaccines and hormones with 19% and 20% market share, respectively. Pfizer: The company has ...
May 23, 2012 at 17:17 | Source: Livemint.com